Inside A Serum Institute Of India Ltd. Pharmaceutical Plant And Interview With Billionaire Chairman Cyrus Poonawalla

Technicians inspect vaccine vials for defects during a screening process at the Serum Institute of India Ltd. pharmaceutical plant in Pune, Maharashtra, India, on Monday, May 4, 2015. Serum, Asia's largest vaccine maker, will look at a possible merger with generic drugmaker Cipla Ltd. if the European venture between the two companies succeeds. Photographer: Sanjit Das/Bloomberg via Getty Images
Technicians inspect vaccine vials for defects during a screening process at the Serum Institute of India Ltd. pharmaceutical plant in Pune, Maharashtra, India, on Monday, May 4, 2015. Serum, Asia's largest vaccine maker, will look at a possible merger with generic drugmaker Cipla Ltd. if the European venture between the two companies succeeds. Photographer: Sanjit Das/Bloomberg via Getty Images
Inside A Serum Institute Of India Ltd. Pharmaceutical Plant And Interview With Billionaire Chairman Cyrus Poonawalla
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
474029528
Collection:
Bloomberg
Date created:
May 04, 2015
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
INDIA SERUM
Max file size:
4000 x 2668 px (13.33 x 8.89 in) - 300 dpi - 4 MB